Susan Duty

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

NPJ Parkinson's disease

Scientific reports

Neuronal signaling

BMC neuroscience

King's College London

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London

United Kingdom

Reader in Pharmacology & Neuroscience :: Pharmacology and Neuroscience

King's College London

United Kingdom

Senior Lecturer in Pharmacology :: Pharmacology

King's College London

United Kingdom

Lecturer in Pharmacology :: Pharmacology

University of Manchester

United Kingdom

Post-doctoral research associate :: Anatomy

University of Sydney

Australia

Post-doctoral research associate :: Physiology

University of Manchester

United Kingdom

Post doctoral research associate :: Pharmacology

Education History

University of Manchester

United Kingdom

PHD :: Pharmacology

University of Manchester

United Kingdom

BSC :: Pharmacology

Publications

Yazead Buhidma, Carl Hobbs, Marzia Malcangio, Susan Duty
Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson's disease. NPJ Parkinson's disease 9 (1) (2023)
Yazead Buhidma, Carl Hobbs, Marzia Malcangio, Susan Duty
Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson's disease. NPJ Parkinson's disease 9 (1) (2023)
Yazead Buhidma, Carl Hobbs, Marzia Malcangio, Susan Duty
Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson's disease. NPJ Parkinson's disease 9 (1) (2023)
Edward J R Fletcher, Thomas Kaminski, Gareth Williams, Susan Duty
Drug repurposing strategies of relevance for Parkinson's disease. Pharmacology research & perspectives 9 (4) (2022)
Joana Lama, Yazead Buhidma, Edward J R Fletcher, Susan Duty
Animal models of Parkinson's disease: a guide to selecting the optimal model for your research. Neuronal signaling 5 (4) (2021)
Yazead Buhidma, Katarina Rukavina, Kallol Ray Chaudhuri, Susan Duty
Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease. NPJ Parkinson's disease 6 (2020)
Edward J R Fletcher, Aran D Jamieson, Gareth Williams, Patrick Doherty, Susan Duty
Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats. Scientific reports 9 (1) (2019)
Edward J R Fletcher, Lawrence D F Moon, Susan Duty
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease. BMC neuroscience 20 (1) (2019)

Susan Duty

Publication Activity (10 Years)

Top Topics

Top Venues